Anissa Abi-Dargham, MD

In this video, 3 experts discuss the challenge of treating schizophrenia with the current medications, which target blockade of dopaminergic receptors, and explore 4 new medications (ulotaront, KarXT, CVL-231,...

Experts discuss the brain circuits involved in schizophrenia, the current medications, and new agents in phase 3 trials that do not directly block postsynaptic D2 receptors. Phase 2 data...